| Visualizaciones | |
|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 48 |
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 0 | 29 | 0 | 7 | 3 | 5 | 4 |
| Visualizaciones | |
|---|---|
| artconlli_a2019_tabernero_josep_binimetinib_encorafenib.pdf | 11 |
| Visualizaciones | |
|---|---|
| Estados Unidos | 17 |
| China | 7 |
| Canadá | 2 |
| Bélgica | 1 |
| España | 1 |
| Visualizaciones | |
|---|---|
| Menlo Park | 10 |
| Shanghai | 6 |
| Oakland | 5 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |
| San Diego | 1 |